Miracle Mile Advisors, LLC Bristol Myers Squibb CO Transaction History

Miracle Mile Advisors, LLC

  • $4.15 Billion
  • Q3 2024

A detailed history of Miracle Mile Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 106,936 shares of BMY stock, worth $6.18 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
106,936
Previous 107,549 0.57%
Holding current value
$6.18 Million
Previous $4.47 Million 23.89%
% of portfolio
0.13%
Previous 0.11%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$39.66 - $51.75 $24,311 - $31,722
-613 Reduced 0.57%
106,936 $5.53 Million
Q2 2024

Jul 18, 2024
BUY
$40.25 - $52.99 $432,647 - $569,589
10,749 Added 11.1%
107,549 $4.47 Million
Q1 2024

Apr 18, 2024
BUY
$47.98 - $54.4 $4.3 Million - $4.87 Million
89,568 Added 1238.5%
96,800 $5.25 Million
Q4 2023

Jan 22, 2024
SELL
$48.48 - $57.85 $41,014 - $48,941
-846 Reduced 10.47%
7,232 $371,000
Q3 2023

Oct 25, 2023
SELL
$57.89 - $64.73 $17,309 - $19,354
-299 Reduced 3.57%
8,078 $468,000
Q2 2023

Jul 13, 2023
BUY
$63.71 - $70.74 $50,904 - $56,521
799 Added 10.54%
8,377 $535,000
Q1 2023

Apr 20, 2023
SELL
$65.71 - $74.53 $52,305 - $59,325
-796 Reduced 9.51%
7,578 $525,000
Q4 2022

Jan 20, 2023
SELL
$68.48 - $81.09 $134,768 - $159,585
-1,968 Reduced 19.03%
8,374 $0
Q3 2022

Oct 24, 2022
SELL
$0.13 - $76.84 $1,235 - $730,210
-9,503 Reduced 47.89%
10,342 $735,000
Q2 2022

Jul 15, 2022
BUY
$72.62 - $79.98 $461,790 - $508,592
6,359 Added 47.15%
19,845 $1.53 Million
Q1 2022

Apr 25, 2022
BUY
$61.48 - $73.72 $558,299 - $669,451
9,081 Added 206.15%
13,486 $985,000
Q4 2021

Jan 18, 2022
SELL
$53.63 - $62.52 $11,208 - $13,066
-209 Reduced 4.53%
4,405 $275,000
Q3 2021

Nov 01, 2021
BUY
$59.17 - $69.31 $37,158 - $43,526
628 Added 15.76%
4,614 $273,000
Q2 2021

Jul 28, 2021
BUY
$61.91 - $67.42 $23,092 - $25,147
373 Added 10.32%
3,986 $266,000
Q1 2021

Apr 29, 2021
SELL
$59.34 - $66.74 $90,968 - $102,312
-1,533 Reduced 29.79%
3,613 $228,000
Q4 2020

Jan 19, 2021
SELL
$57.74 - $65.43 $16,167 - $18,320
-280 Reduced 5.16%
5,146 $319,000
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $30,552 - $33,856
-532 Reduced 8.93%
5,426 $327,000
Q2 2020

Aug 06, 2020
SELL
$54.82 - $64.09 $324,041 - $378,835
-5,911 Reduced 49.8%
5,958 $350,000
Q1 2020

May 11, 2020
BUY
$46.4 - $67.43 $550,721 - $800,326
11,869 New
11,869 $662,000
Q2 2019

Aug 07, 2019
SELL
$44.62 - $49.34 $1.47 Million - $1.63 Million
-33,000 Closed
0 $0
Q1 2019

May 07, 2019
BUY
$45.12 - $53.8 $1.49 Million - $1.78 Million
33,000 New
33,000 $1.57 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Miracle Mile Advisors, LLC Portfolio

Follow Miracle Mile Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email